{
    "nctId": "NCT02408120",
    "officialTitle": "Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes Treated With Basal Bolus Insulin Regimen",
    "inclusionCriteria": "1. Subjects admitted to the hospital with acute or chronic medical illnesses or for elective and emergency surgical illness or trauma\n2. Known history of Type 2 diabetes mellitus for \\>3 months\n3. Treated with either diet alone, any combination of oral antidiabetic agents, non-insulin injectables or insulin therapy\n4. Blood glucose levels between \\>140 mg and \\<400 mg/dL without laboratory evidence of diabetic ketoacidosis\n* Must have minimum age of 18 Years\n* Must have maximum age of 80 Years",
    "exclusionCriteria": "1. Hyperglycemia without a history of diabetes\n2. Subjects with acute critical illness admitted to the ICU or expected to require ICU admission\n3. Subjects receiving continuous insulin infusion\n4. Clinically relevant hepatic disease\n5. Corticosteroid therapy\n6. Serum creatinine \u2265 3.5 mg/dL and/or glomerular filtration rate (GFR) \\<30\n7. Subjects unable to sign consent\n8. Pregnancy"
}